Charles Berkman

(Mr. Charles Berkman J.D.)

Currently holds a position at Ligand Pharmaceuticals Inc

Positions

Position Company Period
Senior Vice President, General Counsel, Secretary Ligand Pharmaceuticals Inc Jan. 1, 2018 -
Vice President, General Counsel, Secretary Ligand Pharmaceuticals Inc April 1, 2007 - Jan. 1, 2018
Charles Berkman's trades of OmniAb Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-04-07 2025-04-07
US OmniAb Inc (OABI)
S Sale
7,206 -1.9%
2.00
USD 14,412 		7,206 -1.9% 2.00 USD 14,412
2025-02-19 2025-02-19
US OmniAb Inc (OABI)
S Sale
7,255 -2.0%
3.67
USD 26,626 		7,255 -2.0% 3.67 USD 26,626
2025-02-19 2025-02-18
US OmniAb Inc (OABI)
S Sale
8,215 -2.2%
3.68
USD 30,231 		8,215 -2.2% 3.68 USD 30,231
2025-01-22 2025-01-21
US OmniAb Inc (OABI)
S Sale
25,489 -6.9%
3.24
USD 82,584 		25,489 -6.9% 3.24 USD 82,584
2024-12-10 2024-12-09
US OmniAb Inc (OABI)
S Sale
8,022 -2.4%
4.13
USD 33,131 		8,022 -2.4% 4.13 USD 33,131
2024-04-09 2024-04-08
US OmniAb Inc (OABI)
S Sale
6,954 -2.3%
5.27
USD 36,648 		6,954 -2.3% 5.27 USD 36,648
2021-02-05 2021-02-04
S Sale
18,097 -38.5%
178.50
USD 3,230,376 		18,097 -38.5% 178.50 USD 3,230,376
2020-06-05 2020-06-04
S Sale
11,146 -21.4%
118.59
USD 1,321,775 		11,146 -21.4% 118.59 USD 1,321,775
// ... existing code ... // ... rest of the file ...